1[1]Ueno H,Nakamura H,Inoue M.Expression and tissue localization of membrane-types 1,2,and 3 matrix metalloproteinases in human invasive breast carcinomas[J].Cancer Res,1997,57(10):2055-2060.
2[2]Zucker S,Lysik RM,Zarrabi MH.Type Ⅳ collagenase is increased in plasma of patients with colon cancer and breast cancer[J].Cancer Res,1993,53 (1):140-146.
3[3]De Nictolis M,Garbisa S,Lucarini G.MMP-2,type Ⅳ collagen,and Ki 67 antigen in serous tumors of the ovary:a clinicopathologic,immunohistochemical,and serological study[J].Int J Gynecol Pathol,1996,15(2):102-109.
4[4]Nawrocki B,Polette M,Marchand V.Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas:quantificative and morphological analyses[J].Int J Cancer,1997,72(4):556-564.
5[5]Ylisirnio S,Hoyhtya M,Turpeenniemi-Hujanen T.Serum matrix metalloproteinases -2,-9 and tissue inhibitors of metalloproteinases -1,-2 in lung cancer--TIMP-1 as a prognostic marker[J].Anticancer Res,2000,20(2B):1311-1316.
6[6]Torii K,Iida K,Miyazaki Y.Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome[J].Am J Respir Crit Care Med,1997,155 (1):43 -46.
7[7]Montironi R,Lucarini G,Castaldini C.Immunohistochemical evaluation of type Ⅳ collagenase (72-kD metalloproteinase) in prostatic intraepithelial neoplasia[J].Anticancer Res,1996,16 (4A):2057-2062.
8[8]Gohji K,Fujimoto N,Hara I,et al.Serum matrix metalloproteinase -2and its density in men with prostate cancer as a new predictor of disease extension[J].lnt J Cancer,1998,79 (1):96-101.
9[9]Liabakk NB,Talbot I,Smith RA.MMP-2 and MMP-9 type Ⅳ collagenases in colorectal cancer[J].Cancer Res,1996,56 (1):190-196.
10[10]Oberg A,Hoyhtya M,Tavelin B.Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2,MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1,TIMP-2) in colorectal cancer[J].Anticancer Res,2000,20(2B):1085-1091.
